This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

The Medicines' CEO Presents At Deutsche Bank Annual Healthcare Conference (Transcript)

The Medicines Company (MDCO)

Deutsche Bank Annual Healthcare Conference Call

May 7, 2012 2:10 pm ET

Executives

Clive A. Meanwell – Chairman and Chief Executive Officer

William B. O’Connor – Vice President and Chief Accounting Officer

Analysts

Navdeep Singh – Deutsche Bank Securities, Inc.

Presentation



Navdeep Singh – Deutsche Bank Securities, Inc.

All right. Good afternoon, everyone, and thanks for joining us in for afternoon session. My name is Navdeep Singh, and I am one of the Biotech Analyst at Deutsche Bank. And it’s my pleasure to announce our next company The Medicines Company. And presenting on behalf of The Medicines Company is Clive Meanwell, Chairman and CEO. We also have Bill O’Connor, the Chief Accounting Officer on the stage today.

And before, we start our presentation I just want to give you guys a heads up. We have this new app that we trying out, we call the [Yorn] app. The instructions to use it are on your desks. And it’s just basically, if you don’t want to ask live question, and you want me to ask it on your behalf, feel free to follow the instructions then I will ask the question on your behalf.

So with that, Clive, you want to take the podium?

Clive A. Meanwell

Thank you very much, Navdeep, and thank you to Deutsche Bank for the invitation to this conference. I was worried that [Yorn] app meant that you had to push a button and there was trap door in the stage, but hopefully, no.

1 of 3

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 16,880.36 -31.75 -0.19%
S&P 500 1,970.07 +0.12 0.01%
NASDAQ 4,462.9020 +20.2040 0.45%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs